Abstract: Collaboration of the Dutch centers for kidney transplantation in children started in 1997 with a shared immunosuppressive protocol, aimed at improving graft survival by diminishing the incidence of acute rejections. This study compares the results of transplantations in these patients to those in a historical reference group. Ninety-six consecutive patients receiving a first kidney transplant were treated with an immunosuppressive regimen consisting of mycophenolate mofetil, cyclosporine and corticosteroids. The results were compared with those of historic controls (first transplants between 1985 and 1995, n = 207), treated with different combinations of corticosteroids, cyclosporine A and/or azathioprine. Cytomegalovirus (CMV) prophylaxis was prescribed to high-risk patients in the study group, and only a small proportion of the reference group. The graft survival at 1 yr improved significantly: 92% in the study group, vs. 73% in the reference group (p < 0.001). In the study group 63% of patients remained rejection-free during the first year; in the reference group 28% (p < 0.001). After statistical adjustment of differences in baseline data, as cold ischemia time, the proportion of LRD, preemptive transplantation, and young donors, the difference between study and reference group in graft survival (RR 0.33, p = 0.003) and incidence of acute rejection (RR 0.37, p < 0.001), as the only factor, remained statistically significant, indicating the effect of the immunosuppressive therapy. In the first year one case of malignancy occurred in each group. CMV disease occurred less frequently in the study group (11%) than in the reference group (26%, p = 0.02). As a new complication in 4 patients bronchiectasis was diagnosed. A new consensus protocol, including the introduction of mycophenolate mofetil, considerably improved the outcome of pediatric kidney transplantation in the Netherlands, measured as reduction of the incidence of acute rejection and improved graft survival.

References

1 Cransberg K, van Gool JD, Davin JC, et al. Pediatric renal transplantation in the Netherlands. Pediatr Transplant 2000: 4: 72–81.
10.1034/j.1399-3046.2000.00079.x
CAS PubMed Google Scholar
2 Postlethwaite RJ, Johnson RJ, Armstrong S, et al. The outcome of pediatric cadaveric renal transplantation in the UK and Eire. Pediatr Transplant 2002: 6: 367–377.
10.1034/j.1399-3046.2002.02027.x
PubMed Web of Science® Google Scholar
3 Tyden G, Berg U. Pediatric renal transplantation in the Nordic countries: a report of the Nordic Pediatric Renal Transplant Study Group. Pediatr Transplant 1998: 2: 240–243.
CAS PubMed Google Scholar
4 Benfield MR, McDonald R, Sullivan EK, Stablein DM, Tejani A. The 1997 annual renal transplantation in children report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Pediatr Transplant 1999: 3: 152–167.
10.1034/j.1399-3046.1999.00011.x
CAS PubMed Google Scholar
5 Matas AJ. Impact of acute rejection on development of chronic rejection in pediatric renal transplant recipients. Pediatr Transplant 2000: 4: 92–99.
10.1034/j.1399-3046.2000.00096.x
CAS PubMed Google Scholar
6 Birk PE, Matas AJ, Gillingham KJ, Mauer SM, Najarian JS, Chavers BM. Risk factors for chronic rejection in pediatric renal transplant recipients – a single center experience. Pediatr Nephrol 1997: 11: 395–398.
10.1007/s004670050303
CAS PubMed Web of Science® Google Scholar
7 Guyot C, Nguyen J-M, Cochat P, et al. Risk factors for chronic rejection in pediatric renal allograft recipients. Pediatr Nephrol 1996: 10: 723–727.
10.1007/s004670050199
PubMed Web of Science® Google Scholar
8 Tejani AH, Stablein DM, Sullivan EK, et al. The impact of donor source, recipient age, preoperative immunotherapy and induction therapy on early and late acute rejections in children: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Pediatr Transplant 1998: 2: 318–324.
CAS PubMed Google Scholar
9 Vanrenterghem Y. Role of acute rejection in chronic rejection. Transplantation 1998: 30: 1210–1211.
10.1016/S0041-1345(98)00213-9
CAS PubMed Web of Science® Google Scholar
10 Elshihabi I, Chavers B, Donaldson L, Emmett L, Tejani A. Continuing improvement in cadaver donor graft survival in North American children: the 1998 annual report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Pediatr Transplant 2000: 4: 235–246.
10.1034/j.1399-3046.2000.00116.x
CAS PubMed Google Scholar
11 McDonald R, Donaldson L, Emmett L, Tejani A. A decade of living donor transplantation in North American children: the 1998 annual report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Pediatr Transplant 2000: 4: 221–234.
10.1034/j.1399-3046.2000.00117.x
CAS PubMed Google Scholar
12 European Mycophenolate Mofetil Cooperative Study Group. Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. Lancet 1995: 345: 1321–1325.
10.1016/S0140-6736(95)92534-1
PubMed Web of Science® Google Scholar
13 TheTricontinentalMycophenolate Mofetil Renal Transplantation Study Group. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. Transplantation 1996: 61: 1029–1037.
10.1097/00007890-199604150-00008
PubMed Google Scholar
14 Halloran P, Mathew T, Tomlanovich S, Groth C, Hooftman L, Barker C. Mycophenolate mofetil in renal allograft recipients: a pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. The International Mycophenolate Mofetil Renal Transplant Study Groups. Transplantation 1997: 63: 39–47.
10.1097/00007890-199701150-00008
CAS PubMed Web of Science® Google Scholar
15 Schwartz GJ, Brion LP, Spitzer A. The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am 1987: 34: 571–590.
10.1016/S0031-3955(16)36251-4
CAS PubMed Web of Science® Google Scholar
16 Morris MC, Allanby CW, Toseland P, Haycock GB, Chantler C. Evaluation of a height/plasma creatinine formula in the measurement of glomerular filtration rate. Arch Dis Child 1982: 57: 611–615.
10.1136/adc.57.8.611
PubMed Web of Science® Google Scholar
17 Pijnenburg MWH, Cransberg K, Wolff ED, Bouquet J, Merkus PJFM. Bronchiectasis in children after renal or liver transplantation: a report of five cases. Pediatr Transplant 2004: 8: 71–74.
10.1046/j.1397-3142.2003.00130.x
PubMed Web of Science® Google Scholar
18 Jungraithmayr T, Staskewitz A, Kirste G, et al. Pediatric renal transplantation with mycophenolate mofetil-based immunosuppression without induction: results after three years. Transplantation 2003: 75: 454–461.
10.1097/01.TP.0000045748.95874.64
CAS PubMed Web of Science® Google Scholar
19 Sageda S, Nordal KP, Hartmann A, et al. The impact of cytomegalovirus infection and disease on rejection episodes in renal allograft recipients. Am J Transplant 2002: 2: 850–856.
10.1034/j.1600-6143.2002.20907.x
Google Scholar
20 Staskewitz A, Kirste G, Tonshoff B, et al. Mycophenolate mofetil in pediatric renal transplantation without induction therapy: results after 12 months of treatment. German Pediatric Renal Transplantation Study Group. Transplantation 2001: 71: 638–644.
10.1097/00007890-200103150-00010
CAS PubMed Web of Science® Google Scholar
21 Mathew TH. A blinded, long-term, randomized multicenter study of mycophenolate mofetil in cadaveric renal transplantation: results at three years. Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group. Transplantation 1998: 65: 1450–1454.
10.1097/00007890-199806150-00007
CAS PubMed Web of Science® Google Scholar
22 Abbott KC, Hypolite IO, Viola R, et al. Hospitalizations for Cytomegalovirus disease after renal transplantation in the United States. Ann Epidemiol 2002: 12: 402–409.
10.1016/S1047-2797(01)00283-6
PubMed Web of Science® Google Scholar
23 Ettenger R, Cohen A, Nast C, Moulton L, Marik J, Gales B. Mycophenolate mofetil as maintenance immunosuppression in pediatric renal transplantation. Transplant Proc 1997: 29: 340–341.
10.1016/S0041-1345(96)00296-5
CAS PubMed Web of Science® Google Scholar
24 ter Meulen CG, Wetzels JF, Hilbrands LB. The influence of mycophenolate mofetil on the incidence and severity of primary cytomegalovirus infections and disease after renal transplantation. Nephrol Dial Transplant 2000: 15: 711–714.
10.1093/ndt/15.5.711
PubMed Web of Science® Google Scholar

Citing Literature

Volume9, Issue1

February 2005

Pages 104-111

Improved outcome of pediatric kidney transplantations in the Netherlands – Effect of the introduction of mycophenolate mofetil?

Abstract

References

Citing Literature

References

Information

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

Improved outcome of pediatric kidney transplantations in the Netherlands – Effect of the introduction of mycophenolate mofetil?

Abstract

References

Citing Literature

References

Related

Information